<?xml version="1.0" encoding="utf-8"?>
<Articles JournalTitle="Iranian Journal of Public Health">
    <Article>
        <Journal>
            <PublisherName>Kowsar</PublisherName>
            <JournalTitle>Arch Clin Infect Dis</JournalTitle>
            <Issn>2345-2641</Issn>
            <Volume>13</Volume>
            <Issue>4</Issue>
            <PubDate PubStatus="epublish">
                <Year>2017</Year>
                <Month>10</Month>
                <Day>31</Day>
            </PubDate>
            <journal_id_doi>10.5812/archcid.62029</journal_id_doi>
        </Journal>
        <title locale="en_US">Emergence of NDM-1-Producing &lt;i&gt;Escherichia coli&lt;/i&gt; in Iran</title>
        <AuthorList>
            <Author>
                <FirstName>Negar</FirstName>
                <LastName>Elahi</LastName>
            </Author>
            <Author>
                <FirstName>Shirin</FirstName>
                <LastName>Eyvazi</LastName>
            </Author>
            <Author>
                <FirstName>Shirin</FirstName>
                <LastName>Eyvazi</LastName>
            </Author>
            <Author>
                <FirstName>Mojdeh</FirstName>
                <LastName>Hakemi-Vala</LastName>
            </Author>
            <Author>
                <FirstName>Mojdeh</FirstName>
                <LastName>Hakemi Vala</LastName>
            </Author>
            <Author>
                <FirstName>Ali</FirstName>
                <LastName>Hashemi</LastName>
            </Author>
            <Author>
                <FirstName>Fatemeh</FirstName>
                <LastName>Bagheri Bejestani</LastName>
            </Author>
        </AuthorList>
        <ArticleType>Case Report</ArticleType>
        <History>
            <PubDate PubStatus="accepted">
                <Year>2017</Year>
                <Month>8</Month>
                <Day>12</Day>
            </PubDate>
            <PubDate PubStatus="received">
                <Year>2017</Year>
                <Month>2</Month>
                <Day>8</Day>
            </PubDate>
            <PubDate PubStatus="epublish">
                <Year>2017</Year>
                <Month>10</Month>
                <Day>31</Day>
            </PubDate>
            <PubDate PubStatus="ppublish">
                <Year>2018</Year>
                <Month>08</Month>
                <Day>30</Day>
            </PubDate>
        </History>
        <abstract locale="en_US">Introduction : Carbapenems are a broad-spectrum class of beta-lactam antibiotics, which are used in treatment of multi-drug resistant infections. Unfortunately, global emerging and spreading of carbapenemase, especially New Delhi metallo β lactamase 1 (
        <i>bla</i>
        <sub>
            <i>NDM-1</i>
        </sub>), is a concern in the treatment of multi drug-resistant agents. Here, we report the appearance of 
        <i>bla</i>
        <sub>
            <i>NDM-1</i>
        </sub>producing 
        <i>Escherichia coli</i>(
        <i>E. coli</i>) in Iran for the first time. Case Presentation : In this study, 2 
        <i>bla</i>
        <sub>
            <i>NDM-1</i>
        </sub>producing 
        <i>E. coli</i>strains were isolated from 2 burn wounds of patients in the Motahari hospital, Tehran. The isolates were resistant to carbapenems (imipenem, meropenem and ertapenem) and other common antibiotics except nitrofurantoin. Combined Disk Test showed that the isolates could not produce 
        <i>bla</i>
        <sub>
            <i>AmpC</i>
        </sub>and 
        <i>bla</i>
        <sub>
            <i>KPC</i>
        </sub>carbapenemase, whereas they can produce metallo-β-lactamases (MBL). However, genetic detection using Polymerase Chain Reaction amplification with specific primers for 
        <i>bla</i>
        <sub>
            <i>KPC</i>
        </sub>, 
        <i>blaI</i>
        <sub>
            <i>MP</i>
        </sub>, 
        <i>bla</i>
        <sub>
            <i>VIM</i>
            <i>-</i>
            <i>1</i>
        </sub>, 
        <i>bla</i>
        <sub>
            <i>VIM</i>
            <i>-</i>
            <i>1</i>
        </sub>– 
        <i>bla</i>
        <sub>
            <i>VIM</i>
            <i>-</i>
            <i>37</i>
        </sub>, and 
        <i>bla</i>
        <sub>
            <i>NDM</i>
            <i>-</i>
            <i>1</i>
        </sub>genes showed that only the 
        <i>bla</i>
        <sub>
            <i>NDM</i>
            <i>-</i>
            <i>1</i>
        </sub>gene is amplified from the resistant isolates. Further sequencing of PCR products confirmed the presence of the 
        <i>bla</i>
        <sub>
            <i>NDM</i>
            <i>-</i>
            <i>1</i>
        </sub>gene in these isolates. Conclusions : The emerging of 
        <i>bla</i>
        <sub>
            <i>NDM</i>
            <i>-</i>
            <i>1</i>
        </sub>producing 
        <i>E. coli</i>is a new threat for to the health system in Iran, due to the spreading of the 
        <i>bla</i>
        <sub>
            <i>NDM-1</i>
        </sub>gene among pathogenic bacteria, which resulted in the emergence of multi drug resistant photogenes. Therefore, early identification of these isolates is mandatory.</abstract>
        <web_url>http://archcid.com/en/articles/62029.html</web_url>
        <pdf_url>https://cdn.neoscriber.org/cdn/dl/7b987bca-bfd3-11e8-af15-7b5b95667a9b</pdf_url>
    </Article>
</Articles>
